| FTHFX | VYSEX | FTHFX / VYSEX | |
| Total Expense Ratio | 0.63 | 0.82 | 77% |
| Annual Report Gross Expense Ratio | 0.63 | 0.82 | 77% |
| Fund Existence | 14 years | 12 years | - |
| Gain YTD | 8.058 | 3.579 | 225% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 11B | 162M | 6,790% |
| Annual Yield % from dividends | 0.70 | 1.65 | 43% |
| Returns for 1 year | -7.07 | -12.21 | 58% |
| Returns for 3 years | 36.08 | 18.77 | 192% |
| Returns for 5 years | 75.98 | -0.95 | -7,998% |
| Returns for 10 years | 157.53 | -12.59 | -1,251% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BCSSX | 48.74 | 0.27 | +0.56% |
| Brown Capital Mgmt Small Co Instl | |||
| HEQFX | 4.93 | N/A | N/A |
| Monteagle Opportunity Equity Inv | |||
| BMGCX | 24.09 | N/A | N/A |
| BlackRock Mid-Cap Growth Equity Inv C | |||
| SSIPX | 14.53 | N/A | N/A |
| State Street International Stock Sel I | |||
| FIJYX | 42.63 | N/A | N/A |
| Fidelity Advisor Biotechnology Z | |||